Passage Bio
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Passage Bio's balance sheet done over the years? Its assets were worth $150,545,000 last year, which is less than in the previous period. 26% of Passage Bio’s total assets is currently financed by debt. Its liabilities reached the amount of $39,262,000, which means an decrease by -7% compared compared to last year.

Debt to Assets

Passage Bio, Inc. (NASDAQ:PASG): Debt to assets
2018 33461000 45.63M 136.38%
2019 178613000 4.26M 2.39%
2020 328007000 23.29M 7.1%
2021 355076000 36.41M 10.26%
2022 243549000 42.18M 17.32%
2023 150545000 39.26M 26.08%

PASG Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
21.70M34.60M128.96M135.00M158.87M24.86M
Short term investments
92.58M155.00M186.80M169.81M00
Net receivables
000000
Inventory
000000
Other current assets
3.66M926K1.72M12.36M6.90M8.53M
Total current assets
117.95M197.04M325.06M317.18M165.77M33.39M
Non-current assets:
Property, Plant and Equipment
32.15M42.23M23.80M2.79M1.08M28K
Goodwill
000000
Intangible assets
000000
Long term investments
000000
Other non-current assets
433K4.26M6.20M5.23M11.75M34K
Total non-current assets
32.58M46.50M30.01M8.02M12.83M62K
Total assets
150.54M243.54M355.07M328.00M178.61M33.46M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000000
Short term debt
6.74M3.27M0000
Total current liabilities
16.34M18.35M29.49M21.17M3.68M307K
Non-current liabilities:
Long term debt
22.92M23.83M0000
Deferred tax
000000
Other non-current liabilities
006.92M2.11M580K45.32M
Total non-current liabilities
22.92M23.83M6.92M2.11M580K45.32M
Total liabilities
39.26M42.18M36.41M23.29M4.26M45.63M
Data sourceData sourceData sourceData source